DoJ extends Biomet DPA

The US Department of Justice (DoJ) extended a foreign bribery deferred prosecution agreement with pharmaceuticals company Biomet for a year in March 2015, the company announced in a US Securities and Exchange Commission filing.


Get unlimited access to all Global Investigations Review content